Gene Query: SNRNP27

Dataset Description Geneva Score
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 46.45
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 35.47
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 35.47
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 33.43
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 27.75
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 27.25
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 27.25
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 25.12
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 25.04
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 17.18
IMP3 regulated gene expression in breast cancer cells 16.07
Transcriptomic analysis of LSD1 14.56
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 12.13
ETV7 and interferon response 11.85
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 11.85
Identification of Nrf2 regulated genes by RNA sequencing 11.43
Nrf2 regulated genes in A549 cells 11.43
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 10.67
Functional role of SLIT2 and ROBO1 in trophoblasts 10.4
Unique features and clinical importance of acute alloreactive immune responses 9.89
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 9.55
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 9.14
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.0
Comprehensive comparative analysis of 5’ end RNA sequencing methods 8.97
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.88
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 8.84
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 8.71
High-throughput sequencing of PROMPT-enriched samples. 8.65
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 8.39
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 8.37
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 8.29
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 7.52
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 7.52
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 7.52
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 7.29
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 7.22
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 7.17
Metastasis in triple-negative breast cancer 7.15
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 7.15
mRNA expression profile of Lymphocytes 6.99
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 6.94
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 6.93
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 6.91
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 6.88
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 6.86
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 6.62
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 6.62
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 6.51
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 6.27
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 6.26
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 6.26
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 6.23
CROP-Seq in Primary Human T Cells 6.23
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 6.08
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 6.06
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 6.05
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 5.92
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 5.9
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 5.82
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.8
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 5.79
DART-seq: an antibody-free method for global m6A detection 5.77
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.74
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 5.69
scRNASeq analysis of cycling cardiomyocytes 5.65
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.65
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 5.6
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 5.39
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 5.37
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 5.34
ARID1A regulates condensin II distribution and chromosomal partition 5.34
Cajal bodies are linked to genome conformation 5.3
Cajal bodies are linked to genome conformation [RNA-Seq] 5.3
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 5.24
Genome-wide analysis of the Integrator complex (HTS) 5.22
Genome-wide analysis of the Integrator complex 5.22
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 5.22
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.19
Direct Isolation and Characterization of Human Nephron Progenitors. 5.15
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 5.13
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 5.13
The landscape of alternative splicing in aggressive prostate cancers 5.12
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 5.06
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 5.06
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 4.99
Tracking of dCas9-methyltransferase footprints 4.97
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.92
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 4.89
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.86
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 4.84
Transcriptional changes in lymphoma cells induced by LSD1 depletion 4.75
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 4.75
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.74
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.7
Global analysis of enhancer targets: Mosaic-seq 4.59
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.56
STX4 Over-Expression in Human islets 4.55
Transcriptional profiling of microglia; current state of the art and future perspectives 4.44
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.44
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 4.43
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.43
FBXW7 modulates stress response by post-translational modification of HSF1 4.43
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.43
RNA-seq analysis to identify the genes regulated by p53-SET interplay 4.4
SUV420H2 knockdown in PANC-1 4.38
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 4.38
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 4.37
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.37
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 4.28
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 4.27
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 4.27
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 4.27
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.22
Gene expression changes after LOC550643 silencing 4.18
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 4.16
MOF acetyl transferase regulates transcription and respiration in mitochondria 4.16
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 4.15
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 4.13
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 4.12
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 4.11
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 4.05
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.01
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 4.0
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 3.95
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.94
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 3.92
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 3.92
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 3.89
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 3.88
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.86
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 3.85
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.81
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 3.8
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 3.79
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 3.79
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 3.77
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 3.76
Impact of dieldrin on transcription in Jurkat T cells 3.75
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 3.68
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 3.68
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 3.65
HNRNPL and its RNA Targets in Prostate Cancer 3.65
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 3.65
U2AF1 mutations alter splice site recognition in hematological malignancies 3.6
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 3.57
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 3.57
Identification of renal resident macrophages across species 3.57
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 3.54
HEK293 TFAM Knockout Expression Study 3.48
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 3.47
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.46
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 3.35
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 3.34
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 3.32
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.32
K562 polyA RNA-Seq 3.3
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.29
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 3.29
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 3.28
Effect of PRDM11 depletion in U2932 cells 3.28
Mutational landscape of splicing genes and functional consequences across 33 cancer types 3.26
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.26
Integrating single-cell transcriptomic data across different conditions, technologies, and species 3.23
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.19
HNF1A deficiency impairs β-cell fate, granule maturation and function 3.15
RNA-sequencing of healthy human skeletal myocytes 3.15
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 3.15
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.14
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 3.14
Global Mapping of Human RNA-RNA Interactions 3.14
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 3.13
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 3.11
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.11
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.08
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 3.07
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.06
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 3.06
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 3.06
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 3.04
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 3.04
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 3.04
RNA-Seq from human ILC transitional populations 3.04
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 3.04
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 3.04
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 3.02
Transcriptional landscape changes during human embryonic stem cell derivation 3.02
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 3.01
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 3.01
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 3.01
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 3.0
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 2.99
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 2.99
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 2.97
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.97
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.96
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 2.94
RNAseq Study in CC-671 Treated Cal-51 Cells 2.93
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.91
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 2.9
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 2.9
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 2.9
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 2.87
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.86
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 2.85
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 2.84
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 2.83
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 2.82
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 2.78
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.74
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 2.71
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 2.7
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 2.7
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 2.7
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 2.7
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.65
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 2.65
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 2.63
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 2.63
Silencing p300 in MCF7 cells to study expression and alternative splicing 2.59
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 2.58
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.57
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.57
Transcriptional effect of ETV1 knockdown in melanoma cells 2.56
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 2.56
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 2.55
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 2.55
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.55
Single-cell analysis of human kidney organoids 2.52
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 2.52
miRNAs affected by antagomiR-17 treatment 2.46
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 2.46
Expression by CD133+ cells isolated from the adult human exocrine pancreas 2.45
Single-nucleotide-resolution mapping of HBV promoters using CAGE 2.44
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 2.42
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 2.42
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.41
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.41
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 2.38
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 2.36
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.35
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.34
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.34
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.32
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 2.3
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.28
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 2.26
PRDM1 inhibits proliferation of human colon cancer organoids 2.24
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.24
Nucleoporin-mediated regulation of cell identity genes 2.23
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 2.19
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.18
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 2.16
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.15
Illumina Total RNA-seq in HeLa 2.15
Regulation of protein translation during mitosis 2.14
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 2.13
RNA-seq of naive and primed ES cells (NHSM) 2.11
Activity-dependent transcriptional changes in human neurons 2.09
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.09
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.09
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.06
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 2.06
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.05
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.03
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.02
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 2.0
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 1.98
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.97
RNA editing in nascent RNA affects pre-mRNA splicing 1.95
Gene expression signatures of innate lymphoid cells from human blood 1.95
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.94
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.94
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.93
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.91
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.9
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.88
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 1.88
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.85
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 1.84
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.84
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.84
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.83
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.82
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 1.82
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 1.82
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.82
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.82
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.81
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.8
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 1.79
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 1.79
Trans-differentiation of human adult peripheral blood T cells into neurons 1.79
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 1.78
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 1.77
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 1.74
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 1.73
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.72
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.71
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.71
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.71
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 1.7
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 1.69
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.69
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.68
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 1.68
O-glcnAc reprograms cellular energetics 1.65
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 1.64
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.62
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.61
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.6
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.59
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.59
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.57
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.57
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.56
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.56
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 1.56
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 1.55
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.54
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.54
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.53
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.51
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.51
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.51
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.51
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.51
Human Treg IL-12 stimulation 1.51
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 1.48
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.46
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 1.46
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 1.46
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 1.46
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.45
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.45
Identification of expressed and conserved human non-coding RNAs 1.44
Single-cell analysis of adult human ovary using 10X genomics 1.44
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.44
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.42
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.41
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.35
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.34
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 1.34
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 1.33
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.33
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 1.31
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.31
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.29
Loss of CREBBP results in gene expression repression in lymphoma cells 1.29
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.28
Epigenome regulation during epidermal lineage commitment [RNA-seq] 1.27
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 1.27
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.27
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.23
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.22
SLAM-seq for K562 endogenous mRNA decay 1.22
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.21
Transcriptome-wide modulation of splicing by the exon junction complex 1.21
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.19
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.18
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.18
Identification of renal resident macrophages across species [C1] 1.15
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.14
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.12
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.1
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.09
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 1.08
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 1.08
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 1.08
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 1.06
Role of COP1 on MAP kinase transcriptional output in melanoma 1.05
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.04
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.02
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 1.02
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 1.01
Effect of from Human Umbilical Vein Endothelial Cells 1.0
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.99
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.99
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.99
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.99
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.98
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.97
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.97
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.95
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.92
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 0.9
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 0.9
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 0.87
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.87
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.86
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.84
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 0.83
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 0.82
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 0.82
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 0.82
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.81
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.81
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.78
Discovering human diabetes-risk gene function with genetics and physiological assays 0.77
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.76
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.74
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.74
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.73
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.73
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.72
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.69
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.67
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 0.67
Global expression profiles in cardiac progenitor cells generated by ISX-9 0.66
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 0.66
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.64
Transcriptome of diurnal human blood neutrophils 0.63
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 0.62
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 0.62
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.61
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.61
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.61
Chromatin landscape of human visceral and subcutaneous adipocytes 0.6
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.6
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.6
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.59
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.57
Transcriptomic analysis of human tonsillar TFH subsets 0.57
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.55
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.54
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.54
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.53
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 0.51
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.49
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.48
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.48
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.48
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.48
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.47
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.45
RNA-Seq and expression data from human adipose tissue 0.45
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 0.42
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 0.42
Functional significance of the HIV-1 Tat signature amino acid residues 0.41
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.4
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.4
High-resolution comparative analysis of great ape genomes 0.4
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.4
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.4
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.4
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 0.39
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.38
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.36
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.35
Epigenome regulation during epidermal lineage commitment 0.35
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.35
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.35
Aneuploidy-induced cellular stresses limit autophagic degradation. 0.32
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.32
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.31
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.31
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.29
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.29
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.28
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.28
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.27
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.26
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.26
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.26
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.25
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 0.25
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.24
Human Treg NaCl stimulation 0.24
Preclinical model of obesity and ER-positive breast cancer 0.24
The cohesin complex prevents Myc-induced replication stress 0.23
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  0.23
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.2
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.17
Gene expression changes due to PARP knockdown in human cells 0.14
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.11
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.11
SNHG5 siRNA knock down in HCT116 cells 0.1
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.1
Human Treg IFNg/IL-10 subpopulations 0.1
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.09
RNA-seq data 0.09
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.07
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.07
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.06
Role of FGFR1 in neuronal devlopment 0.06
Oncogenic roles of ARID5B in T-ALL 0.06
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.06
Myc activation coordinates gene transcription and protein translation responses 0.06
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.05
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.04
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.03
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.03
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.03
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.02
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.02
MHC Transcriptomic landscape at haplotype-specific resolution 0.02
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.02
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.01
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.01
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.01
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation